Compounds > melatonin

melatonin and docetaxel anhydrous

melatonin has been researched along with docetaxel anhydrous in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (55.56)24.3611
2020's4 (44.44)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Alonso-González, C; Cos, S; González, A; González-González, A; Martínez-Campa, C; Menéndez-Menéndez, J1
Baş, E; Nazıroğlu, M1
Ataizi, ZS; Ertilav, K; Nazıroğlu, M1
Alonso-González, C; Cos, S; García Nieto, E; Gómez-Arozamena, J; González, A; González-González, A; Martínez-Campa, C; Menéndez-Menéndez, J; Sánchez-Fernández, C1
Alonso-González, C; Cos, S; González, A; González-González, A; Martínez-Campa, C; Menéndez, JM; Mitola, S; Rueda, N1
Ataizi, ZS; Ertilav, K; Nazıroğlu, M; Yıldızhan, K1
Anisimov, VN; Artemyeva, AS; Baldueva, IA; Belyaev, AM; Golubev, AG; Kireeva, GS; Kruglov, SS; Maydin, MA; Panchenko, AV; Tyndyk, ML1
Song, Y; Wang, S1

Other Studies

9 other study(ies) available for melatonin and docetaxel anhydrous

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Melatonin enhances the apoptotic effects and modulates the changes in gene expression induced by docetaxel in MCF‑7 human breast cancer cells.
    International journal of oncology, 2018, Volume: 52, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Proliferation; Docetaxel; Female; Humans; MCF-7 Cells; Melatonin; Taxoids; Transcriptome

2018
Treatment with melatonin and selenium attenuates docetaxel-induced apoptosis and oxidative injury in kidney and testes of mice.
    Andrologia, 2019, Volume: 51, Issue:8

    Topics: Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Disease Models, Animal; Docetaxel; Drug Therapy, Combination; Humans; Kidney; Kidney Diseases; Male; Melatonin; Mice; Neoplasms; Oxidative Stress; Reactive Oxygen Species; Selenium; Testicular Diseases; Testis; Treatment Outcome

2019
Mitochondrial oxidative stress-induced brain and hippocampus apoptosis decrease through modulation of caspase activity, Ca
    Metabolic brain disease, 2019, Volume: 34, Issue:4

    Topics: Animals; Antioxidants; Apoptosis; Brain; Calcium; Caspases; Cytokines; Docetaxel; Glutathione; Glutathione Peroxidase; Hippocampus; Lipid Peroxidation; Melatonin; Mice; Mitochondria; Neuroprotective Agents; Oxidative Stress; Reactive Oxygen Species; Selenium; TRPM Cation Channels

2019
Melatonin Modulation of Radiation and Chemotherapeutics-induced Changes on Differentiation of Breast Fibroblasts.
    International journal of molecular sciences, 2019, Aug-13, Volume: 20, Issue:16

    Topics: Adipocytes; Antineoplastic Agents; Aromatase; Breast Neoplasms; Cancer-Associated Fibroblasts; CCAAT-Enhancer-Binding Protein-alpha; Cell Differentiation; Docetaxel; Enzyme Activation; Female; Gene Expression Regulation; Humans; Mammary Glands, Human; Melatonin; PPAR gamma; Prostaglandin-Endoperoxide Synthases; Radiation, Ionizing; Vinorelbine

2019
Usefulness of melatonin as complementary to chemotherapeutic agents at different stages of the angiogenic process.
    Scientific reports, 2020, 03-16, Volume: 10, Issue:1

    Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Docetaxel; Drug Synergism; Gene Expression; Human Umbilical Vein Endothelial Cells; Humans; Insulin-Like Growth Factor I; Jagged-1 Protein; Melatonin; Neoplasms; Neovascularization, Pathologic; Receptor, Fibroblast Growth Factor, Type 3; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor D; Vinorelbine

2020
Melatonin and Selenium Suppress Docetaxel-Induced TRPV1 Activation, Neuropathic Pain and Oxidative Neurotoxicity in Mice.
    Biological trace element research, 2021, Volume: 199, Issue:4

    Topics: Animals; Calcium; Docetaxel; Male; Melatonin; Mice; Neuralgia; Oxidative Stress; Selenium; TRPM Cation Channels; TRPV Cation Channels

2021
Melatonin Administered before or after a Cytotoxic Drug Increases Mammary Cancer Stabilization Rates in HER2/Neu Mice.
    Chemotherapy, 2020, Volume: 65, Issue:1-2

    Topics: Anemia; Animals; Antineoplastic Agents; Blood Cell Count; Breast Neoplasms; Cyclophosphamide; Disease Models, Animal; Docetaxel; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Leukopenia; Melatonin; Mice; Mice, Transgenic; Receptor, ErbB-2

2020
Melatonin synergistically enhances docetaxel induced endoplasmic reticulum stress to promote apoptosis by suppressing NF-κB activation in cervical cancer.
    Medical oncology (Northwood, London, England), 2023, Jul-03, Volume: 40, Issue:8

    Topics: Apoptosis; Cell Line, Tumor; Docetaxel; Endoplasmic Reticulum Stress; Female; Humans; Melatonin; NF-kappa B; Uterine Cervical Neoplasms

2023